The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor.

There was also a clear trend that the triple-negative cancer patients from the same cohort with higher AKT1 expression ( n = 74) also had poorer DFS as compared to those with lower levels ( n = 38) ( p = 0.055), although only border significance was achieved (Fig. 1e ) [ 23 ].

also in 19,460 other papers